Melospeech Inc. Accepts Nomination for HealthTech Startup of the Year

SAN DIEGO - Amzeal -- Melospeech Inc., a leading innovator in early-intervention and pediatric speech therapy technology, announced today that it has officially accepted its nomination for HealthTech Startup of the Year in the United States for the Northern American Startup Awards, Edition 11.

This nomination recognizes Melospeech Inc.'s impact in advancing technology-enabled speech therapy, expanding access for underserved families, and building scalable tools that help practices operate with greater efficiency. Finalists across the Global Startup Awards network represent the top emerging companies, with 16 past finalists reportedly achieving unicorn status.

"We're excited to stand alongside so many other health tech start-ups in officially accepting this nomination," said Dr. Givona Sandiford, founder and CEO of Melospeech Inc. "Our team was genuinely surprised by the recognition. We're just a small group of therapists, developers, and educators working to reach as many underserved children as we can — and technology is what makes that possible."

More on Amzeal News

• UK Financial Ltd Announces CoinMarketCap Supply Verification And Market Positioning Review For Regulated Security Tokens SMPRA And SMCAT
• Central Florida Startup Turns Missed Calls Into Booked Revenue With Human-Grade AI Voice Receptionists
• Sharpe Automotive Redefines Local Car Care with "Transparency-First" Service Model in Santee
• The Light Academy: Digital Infrastructure Platform for Family-Directed Education
• Glossa Launches Activity History for Complete Requirements Auditability

Kelli Bavaro, Deputy CEO of Melospeech Inc., also shared her perspective on the company's nomination and use of proprietary technology.

"As a speech-language pathologist, I've seen firsthand how powerful it is when we meet families where they are—both physically and culturally," said Bavaro. "What makes Melospeech so unique is our commitment to using technology and innovation that's truly built for our field, allowing us to better and more quickly serve communities in need."

The nomination also provides opportunities for Melospeech Inc. to gain additional visibility within the global innovation ecosystem, connect with influential industry leaders, and access potential investment opportunities through GSA Ventures.

Melospeech Inc. will complete the next phase of the awards process and looks forward to the opportunity to represent the healthtech community on both national and international stages.

More on Amzeal News

• e-ImageData Receives Platinum Recognition for ScanPro® All-In-One™ in the 2026 Modern Library Awards
• Secondesk Launches Powerful AI Tutor That Speaks 20+ Languages
• Automation, innovation in healthcare processes featured at international conference in Atlanta
• A High-Velocity Growth Story Emerges in Marine and Luxury Markets
• $26 Billion Global Market by 2035 for Digital Assets Opens Major Potential for Currency Tech Company with ATM Expansion and Deployment Plans Underway

About Melospeech Inc.
Melospeech Inc. is a nationally recognized pediatric speech therapy provider specializing in early intervention, parent empowerment, and community-based care. Through innovative technology—including the MeloSuite, the SLPeaceBot™, and other proprietary tools—Melospeech has expanded its reach across underserved regions while streamlining clinical workflows and improving outcomes. Founded by Dr. Givona Sandiford, Melospeech has grown from a solo practice into a multi-state organization providing tens of thousands of sessions each year.